• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.53% Nasdaq Up0.11%

    PharmAthene, Inc. (PIP)

    -NYSE MKT
    1.80 Up 0.04(2.27%) 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 10,190   17,913   25,176  
    Cost of Revenue -   -   -  
    Gross Profit 10,190   17,913   25,176  
    Operating Expenses
    Research Development9,320  15,290  19,510  
    Selling General and Administrative10,912  13,279  11,629  
    Non Recurring -   -   -  
    Others150  182  304  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (10,191) (10,839) (6,266)
    Income from Continuing Operations
    Total Other Income/Expenses Net508  (451)1,867  
    Earnings Before Interest And Taxes(9,683)(11,290)(4,400)
    Interest Expense210  367  325  
    Income Before Tax(9,894)(11,657)(4,725)
    Income Tax Expense62  62  196  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(9,955)(11,718)(4,920)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (9,955) (11,718) (4,920)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (9,955) (11,718) (4,920)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.